Search Results

You are looking at 1 - 5 of 5 items for :

  • "abatacept" x
Clear All

., Ytterberg, S. R., et al.: A randomized double-blind trial of abatacept and glucocorticoids for the treatment of giant cell arteritis. Arthritis Rheumatol., 2015, 67 (Suppl. 10

Restricted access

2563 2571 Genovese, M. C., Becker, J. C., Schiff, M. és mtsai: Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition. N. Engl. J

Restricted access
Orvosi Hetilap
Authors: Zoltán Hella, László Hodinka, Piroska Turbucz and Gábor László Kovács

, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for the treatment of rheumatoid arthritis not previously treated with disease-modifying antirheumatic drugs and after the failure of conventional

Restricted access
Orvosi Hetilap
Authors: Tamás Gáti, Attila Pajor, Pál Géher and György Nagy

Harigai, M.: CTLA4-Ig (abatacept). Nippon Rinsho., 2007, 65 , 1231–1237. Harigai M. CTLA4-Ig (abatacept) Nippon Rinsho

Restricted access
Orvosi Hetilap
Authors: Zoltán Szekanecz, Izabella Gomez, Boglárka Soós, Levente Bodoki, Szilvia Szamosi, Csilla András, Balázs Juhász, László Váróczy, Péter Antal-Szalmás, Péter Szodoray, Nóra Bittner, Péter Árkosy, Árpád Illés, Gabriella Szűcs, Katalin Dankó, Tamás Bender, László Tamási and Éva Szekanecz

, Frisell T, Askling J, et al. Malignant neoplasms in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors, tocilizumab, abatacept, or rituximab in clinical practice: a

Open access